HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis
- 1 January 1994
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 106 (1) , 160-167
- https://doi.org/10.1016/s0016-5085(94)95085-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Critical Role for Conserved Residues in the Cleft of HLA-A2 in Presentation of a Nonapeptide to T CellsScience, 1992
- HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis.Gut, 1992
- Identification of a Mislabeled Fixed Specimen by DNA AnalysisThe American Journal of Surgical Pathology, 1990
- Association of Primary Sclerosing Cholangitis with HLA-DRw52aNew England Journal of Medicine, 1990
- Analysis of HLA-DQ Genotypes and Susceptibility in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1990
- Statistics in Medicine: Calculating confidence intervals for survival time analysesBMJ, 1988
- Association of HLA‐DR4/Dw4 and DR2/Dw2 with radiologic changes in a prospective study of patients with rheumatoid arthritisArthritis & Rheumatism, 1984
- Association of primary sclerosing cholangitis with HLA-B8.Gut, 1983
- Immunological Aspects of Chronic Active HepatitisHepatology, 1983
- HLA Antigens and Immunoregulatory T Cells in Ulcerative Colitis Associated with Hepatobiliary DiseaseScandinavian Journal of Gastroenterology, 1982